• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意外玻璃体内地塞米松注射入晶状体的处理:一例报告

Management of Accidental Intravitreal Dexamethasone Injection Into the Lens: A Case Report.

作者信息

Siotto Pintor Emanuele, Demarinis Giuseppe, Tatti Filippo, Peiretti Enrico

机构信息

Department of Surgical Sciences, Eye Clinic, University of Cagliari, Cagliari, ITA.

出版信息

Cureus. 2023 Mar 16;15(3):e36216. doi: 10.7759/cureus.36216. eCollection 2023 Mar.

DOI:10.7759/cureus.36216
PMID:37073199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10105898/
Abstract

An accidental injection of a dexamethasone implant inside the crystalline lens was observed in the right eye of a 63-year-old woman suffering from a macular edema secondary to a central retinal vein occlusion. A 23-gauge pars plana vitrectomy and lensectomy followed by an intraocular lens implantation were performed to carefully remove the lens and save the whole implant in order to preserve its therapeutics effects. A strict follow-up over the following 3 months revealed an improving of macular edema and no postoperative complications. The injection of a dexamethasone implant into the lens could be effectively and successfully managed with a pars plana vitrectomy and lensectomy.

摘要

在一名63岁患有继发于视网膜中央静脉阻塞的黄斑水肿的女性右眼,观察到地塞米松植入物意外注入晶状体。随后进行了23G经平坦部玻璃体切除术和晶状体切除术,接着植入人工晶状体,以小心地取出晶状体并保存整个植入物,以保留其治疗效果。在接下来的3个月里进行严格随访,结果显示黄斑水肿有所改善且无术后并发症。通过经平坦部玻璃体切除术和晶状体切除术,可以有效且成功地处理将地塞米松植入物注入晶状体的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ce/10105898/7c84dc1b856b/cureus-0015-00000036216-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ce/10105898/7cef05a60d65/cureus-0015-00000036216-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ce/10105898/7c84dc1b856b/cureus-0015-00000036216-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ce/10105898/7cef05a60d65/cureus-0015-00000036216-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65ce/10105898/7c84dc1b856b/cureus-0015-00000036216-i02.jpg

相似文献

1
Management of Accidental Intravitreal Dexamethasone Injection Into the Lens: A Case Report.意外玻璃体内地塞米松注射入晶状体的处理:一例报告
Cureus. 2023 Mar 16;15(3):e36216. doi: 10.7759/cureus.36216. eCollection 2023 Mar.
2
Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma.视网膜母细胞瘤患儿放射性白内障的玻璃体扁平部晶状体切除术及人工晶状体植入术
Ophthalmology. 2005 Sep;112(9):1620-4. doi: 10.1016/j.ophtha.2005.04.017.
3
Unintentional injection of a dexamethasone implant into the crystalline lens: a case report.无意将地塞米松植入剂注入晶状体:一例报告。
Arq Bras Oftalmol. 2020 Jun;83(3):246-249. doi: 10.5935/0004-2749.20200066. Epub 2020 May 29.
4
Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.地塞米松玻璃体内植入剂(Ozurdex)意外注射入晶状体。
Eur J Ophthalmol. 2014 Jul-Aug;24(4):633-6. doi: 10.5301/ejo.5000439. Epub 2014 Feb 25.
5
Pars plana vitrectomy and re-directing a dexamethasone implant into vitreous cavity following misdirected entry into the crystalline lens.经晶状体错误进入后行扁平部玻璃体切除术,并将地塞米松植入物重新引导至玻璃体腔。
Indian J Ophthalmol. 2018 Jul;66(7):1033-1036. doi: 10.4103/ijo.IJO_1179_17.
6
Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.玻璃体内注射地塞米松植入物治疗抗VEGF治疗耐药的视网膜静脉阻塞患者的疗效和安全性:一项为期12个月的前瞻性研究。
Cutan Ocul Toxicol. 2019 Dec;38(4):330-337. doi: 10.1080/15569527.2019.1614020. Epub 2019 May 27.
7
Combined pars plana lensectomy-vitrectomy with open-loop flexible anterior chamber intraocular lens (AC IOL) implantation for subluxated lenses.联合扁平部晶状体切除术-玻璃体切除术及开放式可弯曲前房型人工晶状体(AC IOL)植入治疗晶状体半脱位
Trans Am Ophthalmol Soc. 2000;98:247-51; discussion 251-3.
8
The effect of pars plana vitrectomy with internal limiting membrane peeling on the durability of the intravitreal dexamethasone implant in the treatment of diabetic macular edema.玻璃体平坦部玻璃体切除术联合内界膜剥除术对玻璃体内地塞米松植入物治疗糖尿病性黄斑水肿疗效持久性的影响
Am J Ophthalmol Case Rep. 2022 Feb 17;26:101401. doi: 10.1016/j.ajoc.2022.101401. eCollection 2022 Jun.
9
Inadvertent intralenticular dexamethasone implant: 1-year follow-up and management.意外晶状体内植入地塞米松:1年随访及处理
Oman J Ophthalmol. 2017 Sep-Dec;10(3):235-237. doi: 10.4103/ojo.OJO_47_2016.
10
The Efficacy of Simultaneous Injection of Dexamethasone Implant and Ranibizumab Into Vitreous Cavity on Macular Edema Secondary to Central Retinal Vein Occlusion.玻璃体腔同时注射地塞米松植入剂与雷珠单抗治疗视网膜中央静脉阻塞继发黄斑水肿的疗效
Front Pharmacol. 2022 Mar 1;13:842805. doi: 10.3389/fphar.2022.842805. eCollection 2022.

引用本文的文献

1
Anterior Segment Optical Coherence Tomography Evaluation of a Dexamethasone Intravitreal Implant in the Crystalline Lens: A Case Report.晶体状体内地塞米松玻璃体内植入物的眼前节光学相干断层扫描评估:病例报告
Int Med Case Rep J. 2025 Jan 7;18:27-32. doi: 10.2147/IMCRJ.S486866. eCollection 2025.

本文引用的文献

1
Surgical removal of inadvertent intralenticular sustained-release dexamethasone implant (ozurdex) and implant one-piece posterior capsule intraocular lens.手术取出意外进入晶状体的缓释地塞米松植入物(Ozurdex)并植入一体式后囊人工晶状体。
Saudi J Ophthalmol. 2020 Dec 28;34(2):145-147. doi: 10.4103/1319-4534.305044. eCollection 2020 Apr-Jun.
2
Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature.玻璃体内注射地塞米松植入剂作为一种用于治疗眼部疾病的缓释给药装置:文献综述
Pharmaceutics. 2020 Jul 26;12(8):703. doi: 10.3390/pharmaceutics12080703.
3
Unintentional injection of a dexamethasone implant into the crystalline lens: a case report.
无意将地塞米松植入剂注入晶状体:一例报告。
Arq Bras Oftalmol. 2020 Jun;83(3):246-249. doi: 10.5935/0004-2749.20200066. Epub 2020 May 29.
4
Ozurdex completely located inside a crystallized lens - Results of 14 months.Ozurdex完全位于晶状体内部——14个月的结果
Am J Ophthalmol Case Rep. 2016 Aug 11;4:38-40. doi: 10.1016/j.ajoc.2016.08.001. eCollection 2016 Dec.
5
Intracrystalline Ozurdex: therapeutic effect maintained for 18 months.晶体内Ozurdex:治疗效果维持18个月。
Int Ophthalmol. 2019 Jan;39(1):207-211. doi: 10.1007/s10792-017-0780-3. Epub 2017 Nov 30.
6
Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema?晶状体囊内缓释地塞米松植入物:对黄斑水肿是否仍有效?
Case Rep Ophthalmol. 2016 Feb 12;7(1):85-9. doi: 10.1159/000444163. eCollection 2016 Jan-Apr.
7
Inadvertent dexamethasone implant injection into the lens body management.晶状体体内意外注射地塞米松植入物的处理
Eur J Ophthalmol. 2014 Jul-Aug;24(4):620-2. doi: 10.5301/ejo.5000436. Epub 2014 Feb 3.
8
Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.地塞米松玻璃体内植入剂(Ozurdex)意外注射入晶状体。
Eur J Ophthalmol. 2014 Jul-Aug;24(4):633-6. doi: 10.5301/ejo.5000439. Epub 2014 Feb 25.
9
Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.地塞米松植入前房内迁移:危险因素、并发症和管理策略。
Ophthalmology. 2014 Jan;121(1):67-71. doi: 10.1016/j.ophtha.2013.06.033. Epub 2013 Jul 24.
10
Split Ozurdex implant: a caution.Ozurdex植入物裂开:一则警示
Can J Ophthalmol. 2013 Feb;48(1):e15-6. doi: 10.1016/j.jcjo.2012.03.033. Epub 2012 Aug 9.